Statement on Changes to APP Interest-Free Limit in Budget 2023

Apr 20, 2023

Finance Minister, Chrystia Freeland, tabled Budget 2023 on March 28, 2023. Budget 2023 contains a proposed increase to the interest-free portion of the 2023 Advance Payments Program from $250,000 to $350,000.

Budget 2023 has been tabled and there are numerous steps in the legislative process that will occur in the coming weeks. Currently, Budget 2023 has not been passed and the various legislative pieces will take time to be enacted and implemented.

Canadian Canola Growers Association (CCGA) will be watching Budget 2023 as it progresses through the legislative process. At this time, we are unable to determine when the proposed regulatory changes to the interest-free portion of an advance may come into effect for the 2023 program year.

As we have done with prior mid-year program changes, CCGA will promptly advise customers about this change once we have more details from Agriculture and Agri-Food Canada. CCGA’s website will be updated when additional information becomes available.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.